

How does Myfembree (Estradiol/Norethindrone/Relugolix) work? A plain-English explanation of its mechanism of action for fibroids and endometriosis.
Estradiol/Norethindrone/Relugolix (Myfembree) works by turning down your body's estrogen production to shrink fibroids and reduce endometriosis tissue, while adding back just enough hormone to protect your bones and prevent severe menopause-like symptoms.
That's the one-sentence version. But if you want to understand why this medication works — and why it was designed with three ingredients instead of one — here's the full explanation in plain English.
To understand Myfembree, it helps to think of your hormonal system like a thermostat. Your brain (specifically the hypothalamus and pituitary gland) acts as the thermostat, and estrogen is the temperature. Here's how each ingredient plays its role:
Relugolix is the primary active ingredient and a GnRH receptor antagonist. Here's what that means:
Your brain naturally releases a hormone called GnRH (gonadotropin-releasing hormone) that tells your pituitary gland to produce LH (luteinizing hormone) and FSH (follicle-stimulating hormone). These hormones then signal your ovaries to produce estrogen and progesterone.
Relugolix blocks the GnRH receptors in your pituitary gland — essentially covering the thermostat so it can't receive the signal. Without that signal, your pituitary stops telling your ovaries to make as much estrogen. Estrogen levels drop significantly.
This matters because uterine fibroids and endometriosis tissue are fueled by estrogen. When estrogen drops:
Think of it like cutting the fuel supply to a fire — the fire doesn't go out completely, but it burns much less intensely.
If Relugolix suppresses estrogen, why add estrogen (Estradiol) and a progestin (Norethindrone Acetate) back in?
Because too little estrogen causes problems too. Without any estrogen, you'd experience significant bone loss, severe hot flashes, vaginal dryness, and other symptoms of menopause. Older medications like Lupron (Leuprolide) suppressed estrogen without any add-back, which limited how long patients could safely use them.
The add-back therapy in Myfembree is carefully dosed:
The result is a Goldilocks zone: estrogen levels low enough to treat fibroids and endometriosis, but high enough to keep your bones and body from suffering the worst consequences of estrogen deprivation.
Most women begin to notice changes within the first few weeks to months of starting treatment:
Because of potential bone density effects, treatment is limited to up to 24 months. Your doctor will monitor your response and bone health throughout treatment.
Estradiol/Norethindrone/Relugolix works while you're taking it. Once you stop the medication:
Several other medications target the same hormonal pathway, but Myfembree has some distinct advantages:
Estradiol/Norethindrone/Relugolix is a well-designed combination that balances effectiveness with tolerability. By blocking estrogen production where it counts while adding back just enough hormone to protect your health, it achieves something older treatments couldn't: meaningful symptom relief without forcing you into full-blown menopause.
Understanding how your medication works can help you stick with treatment and recognize what's normal versus what needs attention. For more on what to expect, check out our guides on side effects and drug interactions.
Find Estradiol/Norethindrone/Relugolix in stock near you with Medfinder →
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.